Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 42 for “"Driver gene"”.
-
Functional translation of malignant peripheral nerve sheath tumour driver gene variants using CRISPR screens
… leading to substantial alterations in observed gene effects and increasing the risk of false-positive results. Notably, this confounding factor was found to be prevalent and unaddressed in other external CRISPR screen datasets, including the entire DepMap dataset. Although further refinement in …
-
CHARACERIZING DRIVER GENE HETEROGENEITY AND CLONAL ORIGIN OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS
… system in which to study early pancreatic tumorigenesis. We used a combination of multi-region and single-cell targeted next generation sequencing to assess the diversity of somatic driver gene mutations in IPMNs. The resulting data, combined with evolutionary modeling, whole exome sequencing, …
-
A tail of two PanCancer projects: Somatic variant identification and driver gene discovery using TCGA
The implementation of next-generation genomic sequencing has exploded over the past dozen years. Large consortia, such as The Cancer Genome Atlas (TCGA); the International Cancer Genetics Consortium (ICGC); and the Pediatric Cancer Genome Projects (PCGP), made great strides in democratizing big …
-
The Regulation of Potential Driver Genes in Colorectal Cancer
… to a patient’s genomic background, with epigenetic treatments fast becoming an emerging field. Two in-house screens combined with bioinformatic analysis of publically available data identified SNF2-related CREBBP Activator Protein (SRCAP) as a potential driver gene of CRC. SRCAP is the core …
-
DIAGNOSTIC POTENTIAL OF TUMOR DNA IN HUMAN MALIGNANCIES
… genome-wide studies have demonstrated that tumorigenesis is driven by genetic alterations in a set of well-defined genes. Importantly the process of metastasis takes decades to develop, providing a large window of opportunity for early detection before the tumor reaches an incurable stage. Early …
-
Analysis of cancerous and pre-cancerous skin lesions to generate a repository for studying the mutation burden of UV
… One way to approach this is to identify all the genetic mutations in skin cancers, and to determine which mutated genes are driver genes, i.e. genes in which mutations promote the development of cancer. Following that, one could use this information to look at mutations in the skin before and …
-
Mutational signatures and spectra to determine the extent to which prior therapy drives the onset of colorectal and endometrial cancer
… of cancer. Therefore, this study utilized next-generation (NGS) and whole genome sequencing (WGS) technologies, to identify both mutational signatures and unique CRC/EC driver gene mutations which may have originated from therapy exposure. This was investigated within the 100K genomes project, …
-
Branching process models for cancer evolution: overview and an application to colorectal cancer initiation
… The model incorporates a complex sequence of driver gene alterations, some of which result in immediate growth advantage, while others have initially neutral effects. We derive analytic estimates for the sizes of premalignant subpopulations, and use these results to compute the waiting time …
-
Functional and Evolutionary Constraints of wtf Killer Meiotic Drivers
Killer meiotic drivers are selfish loci that bias their own transmission into the next generation by destroying gametes that do not inherit them from a heterozygous (driver+/driver-) diploid. The wtf gene family in the fission yeast species, Schizosaccharomyces, is rapidly evolving and has multiple …
-
Uncovering Novel Drivers of Mammary Tumorigenesis and Osteosarcoma Chemotherapy Resistance
… subsets of the disease, the enormous heterogeneity in gene expression, genome arrangement, clinical behavior, and phenotype makes identifying driver genes and the cells of origin challenging. Known breast cancer driver gene mutations that have been identified fail to show absolute …
-
Multi-modal profiling reveals epithelial hierarchy disorganization underlying field cancerization in head and neck cancer
… model assumes these "at-risk" tissues share driver mutations with adjacent tumors, but whether field cancerization depends solely on mutations remains unknown. To comprehensively characterize this phenomenon, we profiled matched tumor, normal-adjacent field (NAF), contralateral normal, and …
-
Characterization Of TM9SF2 And WAC As Novel Colorectal Cancer Driver Genes
… on the characterization of two candidate cancer genes, TM9SF2 and WAC, and their role in colorectal cancer (CRC). Interest in these two genes stems from their discovery as frequently mutated genes in a mouse-based CRC mutagenesis screen. The first chapter will discuss CRC and provide an …
-
A genomic investigation of Marek's disease lymphomas
… a bZIP transcription factor and the viral oncogene for pathogenic strains of Marek's disease virus (MDV), is required to induce CD4 T cell lymphomas that characterize Marek's disease (MD) in chickens. However, Meq is not sufficient for neoplastic transformation as not all birds infected with …
-
Characterisation of the genomes of brain metastases
<p>Brain metastases are generally associated with a poor prognosis. The number of metastases, location and control of extracranial disease typically influences the management of patients. Treatment options are currently limited and are dependent on the clinical context. Interventions include …
-
Μελέτη ορθοκολικού καρκίνου με μικροδορυφορική αστάθεια
… with MMR status, clinicopathological data, driver gene mutations (KRAS, NRAS, BRAF) as well as their impact on patients’ overall survival have also been examined. Our results indicated a possible crosstalk between MAPK and PI3k/Akt axes, as KRAS mutations were significantly associated with …
-
Perturbations of interactome networks in acute lymphoblastic leukaemia: identification of EXT1 tumor suppressor as a Notch pathway regulator
… efforts to compare and categorize mutations, genes expression and genomic characteristics helped generating literature-curation databases. A large number of databases were developed to address data integration and standardization for human cancers, such as Catalogue Of Somatic Mutations In …
-
Genomic Characterization of Familial Pancreatic Cancer Leads to Discovery of a Novel Structural Variant in Cancer
… dramatic increases in the survival of cancer in general over the last 5 decades, the 5-year survival of pancreatic ductal adenocarcinoma (PDAC) remains relatively unchanged at 6%. Approximately 10% of PDAC cases are familial pancreatic cancer (FPC), involving two or more affected first-degree …
-
Immunotherapeutic Approaches Targeting Genetic Alterations in Cancer
… have revealed that cancer is—in essence—a genetic disease. Genetic alterations in cancer provide unique signatures that can distinguish between cancer and normal cells in unequivocal fashion. However, significant obstacles remain in developing methods to harness the immune response to …
-
Screening for DUSP4/6 small molecule inhibitors in lung adenocarcinoma
… the need for novel therapeutics with new gene targets and mechanisms of action. Patients with lung adenocarcinoma (LUAD) have a number of driver gene mutations that upregulate signaling through the mitogen activated protein kinase (MAPK) signaling pathway, and its key effectors, the …
-
Circulating tumour DNA as a biomarker in metastatic bladder cancer
… in bladder cancer. In this thesis, next-generation sequencing assays were applied to cfDNA and tumour tissue from patients with muscle-invasive or metastatic bladder cancer. In the majority of patients with metastasis, but few patients with localized disease, tumour-derived cfDNA (i.e., …
Page 1 of 3